Multiple Sclerosis (MS) Clinical Trials

Find Multiple Sclerosis (MS) Clinical Trials Near You

Fatigue in MS: From Invisible to Measurable

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Fatigue is one of the most common and burdensome symptoms of MS, but its precise cause remains unknown, and an effective treatment is lacking. Previous research has shown that the progression of MS is associated with a higher presence of a specific type of T-cell, the cytotoxic CD4+ T-cells, which play a role in the immune system. The aim of this study is to investigate whether these cells can also be linked to fatigue in people with MS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Diagnosis of relapsing remittion, primary progressive or secondary progressive MS

• Age: 18-60 years

• Ability to perform the foot-tapping task

• Ability to walk at least 20 meters (with or without walking aid)

Locations
Other Locations
Netherlands
UMCG
RECRUITING
Groningen
Contact Information
Primary
Nikki Dreijer
n.dreijer@umcg.nl
+31625647172
Time Frame
Start Date: 2025-10-27
Estimated Completion Date: 2026-04-30
Participants
Target number of participants: 40
Treatments
MS
Participants with multiple sclerosis
Related Therapeutic Areas
Sponsors
Leads: University Medical Center Groningen
Collaborators: UHasselt

This content was sourced from clinicaltrials.gov